Anlotinib Plus Penpulimab (AK105) for Chemo-refractory Metastatic Colorectal Cancer:ALTER-C003

NIAID Data Ecosystem2026-03-13 收录

结直肠癌联合治疗临床试验

靶向免疫联合用药评估

数据链接：

https://www.omicsdi.org/dataset/ecrin-mdr-crc/2383996 数据链接链接失效反馈

官方服务：

资源简介：

A single-arm, open-label clinical trial, focus on the safety and efficacy of anlotinib hydrochloride in combination with Penpulimab (AK105) in patients with Chemo-refractory Metastatic Colorectal Cancer (mCRC)

创建时间：

2021-11-15

Anlotinib Plus Penpulimab (AK105) for Chemo-refractory Metastatic Colorectal Cancer:ALTER-C003

资源简介：

相关数据集